Newly developed colorimetric drug screening assay for Bacillus anthracis

被引：6

作者：

Barrow, EW ^{[1
]}

Valderas, MW ^{[1
]}

Bourne, PC ^{[1
]}

Barrow, WW ^{[1
]}

机构：

[1] Oklahoma State Univ, Ctr Vet Hlth, Dept Vet Pathobiol, Stillwater, OK 74078 USA

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2006年 / 27卷 / 02期

关键词：

D O I：

10.1016/j.ijantimicag.2005.12.001

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：178 / 180

页数：3

共 8 条

[1] Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim [J].

Barrow, EW ;

Bourne, PC ;

Barrow, WW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4643-4649

[2]

Clinical and Laboratory Standards Institute (CLSI), 2005, PERF STAND ANT SUSC

[3] ANTIMICROBIAL SUSCEPTIBILITY OF BACILLUS-ANTHRACIS [J].

DOGANAY, M ;

AYDIN, N .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, 23 (03) :333-335

[4]

Lightfoot N.F., 1990, Salisbury Med. Bull, V68, P95

[5] Antimicrobial susceptibility testing of Bacillus anthracis:: Comparison of results obtained by using National Committee for Clinical Laboratory Standards broth microdilution reference and etest agar gradient diffusion methods [J].

Mohammed, MJ ;

Marston, CK ;

Popovic, T ;

Weyant, RS ;

Tenover, FC .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :1902-1907

[6]

NCCLS, 2003, METH DIL ANT SUSC TE

[7]

*NCCLS, 2004, PERF STAND ANT SUSC

[8]

NCCLS (National Committee for Clinical Laboratory Standards), 2002, PERF STAND ANT SUSC

← 1 →